M&A Deal Summary

Arlington Capital Partners Acquires AVS Bio

On January 5, 2023, private equity firm Arlington Capital Partners acquired life science company AVS Bio from Charles River Laboratories International

Acquisition Highlights
  • This is Arlington Capital Partners’ 4th transaction in the Life Science sector.
  • This is Arlington Capital Partners’ 52nd transaction in the United States.
  • This is Arlington Capital Partners’ 1st transaction in Connecticut.

M&A Deal Summary
Date 2023-01-05
Target AVS Bio
Sector Life Science
Buyer(s) Arlington Capital Partners
Sellers(s) Charles River Laboratories International
Deal Type Divestiture

Target

AVS Bio

Norwich, Connecticut, United States
AVS Bio is a provider of specific pathogen free eggs and adjacent laboratory products and services that support the development and manufacture of vaccines, therapeutics, and other biologics used for human and animal health. AVS Bio was founded in 1961 and is based in Norwich, Connecticut.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Arlington Capital Partners

Chevy Chase, Maryland, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1999
PE ASSETS 7.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Arlington Capital Partners is a middle-market private equity firm focused on buyouts and recapitalizations in targeted growth industries. Arlington targets US based companies valued between $50 and $500 million with strong potential for organic growth and possible consolidation opportunities. Sectors of interest include business services and outsourcing, aerospace/defense, federal and commercial IT, media, education and training, healthcare services, and manufacturing. Arlington Capital was formed in 1999 and is headquartered in Washington DC.

DEAL STATS #
Overall 56 of 65
Sector (Life Science) 4 of 4
Type (Divestiture) 8 of 8
State (Connecticut) 1 of 2
Country (United States) 52 of 61
Year (2023) 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-07 Octo

Reston, Virginia, United States

Octo is a provider of digital services for the Federal Government. Octo specializes in providing agile software development, user experience design, and cloud engineering services that address the government’s most pressing missions and modernization challenges. Octo is based in Reston, Virginia.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-03-21 Eqlipse Technologies

Herndon, Virginia, United States

Eqlipse Technologies provides products and high-end engineering services to ensure customers in the Department of Defense and Intelligence Community succeed in their most critical missions. The company's capabilities in virtual operations, identity management, signals intelligence, and full-spectrum cyber and online operations, align with its state-of-the-art scientific research and technology services, ensuring that essential national security agencies operate at the speed of innovation as their missions evolve to new battlefields. Eqlipse Technologies is based in Herndon, Virginia.

Buy -

Seller(S) 1

SELLER

Charles River Laboratories International

Wilmington, Massachusetts, United States
Category Company
Founded 1947
Sector Life Science
Employees20,400
Revenue 4.1B USD (2023)
DESCRIPTION

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Divestiture) 2 of 2
State (Connecticut) 1 of 1
Country (United States) 2 of 2
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-06 Explora BioLabs

San Diego, California, United States

Explora BioLabs provides vivarium and contract research services to companies ranging from early-stage biotechs to large pharma. Explora's Ph.D.-backed suite of Vivarium-as-a-Service solutions provides the vivarium-related resources that biotechnology organizations need to begin in vivo studies in as little as two weeks. Whether operating out of their own vivarium or utilizing Explora's growing network of nationwide facilities, clients have access to Explora's experienced vivarium management, facility design, rodent housing and caging equipment, supply chain management, regulatory compliance, and veterinary oversight. For clients whose research programs or internal expertise is at capacity, Explora offers preclinical contract research staff and services to support the design and execution of preclinical studies for oncology, metabolic diseases, pharmacokinetics, non-GLP toxicology, pain, and a variety of other common therapeutic areas. Explora BioLabs is based in San Diego, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-30 SAMDI Tech

Chicago, Illinois, United States

SAMDI Tech is a provider of high-quality, label-free high-throughput screening (HTS) solutions for drug discovery research. SAMDI Tech offers a proprietary mass spectrometry (MS) technology for high-throughput analysis of biochemical activities and affinity selection MS (SAMDI ASMS) for identifying binding interactions. SAMDI Tech was founded in 2011 and is based in Chicago, Illinois.

Buy $50M
Mergr

Product

Company

Legal